Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 May 24 424B3 Prospectus supplement
- 3 Oct 22 424B4 Prospectus supplement with pricing info
- 30 Sep 22 EFFECT Notice of effectiveness
-
2 Sep 22 S-1/A IPO registration (amended)
- 19 Aug 22 S-1 IPO registration
PBLA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation in this Registration Statement on Form S-1 of our report dated March 24, 2022, relating to the consolidated financial statements of Panbela Therapeutics, Inc. and Subsidiary (the ”Company”) appearing in the Annual Report on Form 10-K of the Company for the years ended December 31, 2021 and 2020, and to the reference to us under the header ”Experts” in this Registration Statement.
/s/ Cherry Bekaert LLP
Tampa, Florida
September 2, 2022